MIAMI, Dec 20 (AFP) - Cuba has defied isolation as the Caribbean's lone communist holdout to build an empire of Asian restaurants, European bars, and African biotech firms, and to peddle its famous Coppelia ice creams and even guayabera shirts abroad.
The reason: a drop-off in foreign investment in Cuba, according to a University of Miami study. And Cuba has found that international capitalism spreads faster than international communism.
Cuba's Ministry for Foreign Investment and Economic Cooperation in 2002 sought to "establish companies in (developing) countries (using) Cuban high technology, specialists and know-how with native manpower," the university's Institute for Cuban and Cuban-American Studies said.
Cuba has capitalized on is best-known brands: the Tropicana night club, La Gloria Cubana cigars and the Bodeguita del Medio, a cramped downtown Havana bar frequented by Ernest Hemingway, thanks to joint ventures abroad.
Cuba's tourism company, Grupo Hotelero Grand Caribe, franchised the "Bodeguita del Medio" restaurant-bar in Dubai, Paris, Prague, Warsaw and five locations in Mexico.
Cuba's biggest tourism group, Cubanacan, earned 300 million dollars in 2002. It joined China's Suntine International-Economic Trading Co. to build a five-star, 700-room hotel in Shanghai.
Cubanacan subsidiary Palmares opened a "La Gloria Cubana" restaurant in Shanghai as a joint venture with Shanshan. It has a "Gloria" franchise in Porto, Portugal, a Tocororo restaurant in Milan and a Daiquiri Scabrous in Panama City.
On the biotech front, Malaysia's Bioven and Havana's CIGB created Heber Bioven to make Cuban biotechnology products in Malaysia for Southeast Asian markets.
Cuba built its pharmaceutical industry on pirated international patents, but today holds 500 patents around the world, the university report said.
In May 2001, Cuban President Fidel Castro himself visited construction of a biotech research and production center outside Tehran, a joint venture of Iran's Pasteur Institute and Havana's Center for Genetic Engineering and Biotechnology (CIGB).
Cuban newspapers called the center "the largest and most modern of its type in the Middle East," with a price tag of 60 million dollars, the university said.
As in most joint ventures, Cuba's contribution is not cash, but technology and the know-how of its scientists, the university noted.
Cuban doctors are famous in Africa, where for years they have provided health care. Namibia's Zenith Enterprises joined Cuba to make basic pharmaceuticals, from penicillin to pain killers. The new plant will soon export Cuban HIV/AIDS formulas to other African countries.
Namibia and Cuba also invested in guayaberas. The loose, four-pocket tropical shirts are de rigeur for day and evening wear and will be stitched with private capital, the university said.
If the line for Coppelia ice cream gets too long in Havana, there is an alternative: It is produced in Ipoh, Malaysia in a joint venture with Jawala Corp.
031220
AF031293
©AFP 2003. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission. obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics. - http://www.afp.com/
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
©1990, 2003 - AEGiS. AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
